Project Grant R21MH135324

Award Date 7/23/24
Completion Date 7/22/26
Dollars Obligated $498K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Washington, DC 20010, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $116,798 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to The University of Texas Southwestern Medical Center. The grant, with a period of performance from September 11, 2024 to August 31, 2026, will fund research to evaluate the impact of the autism risk gene FOXP1 on early neocortical development, specifically examining its effects on neuronal migration and cell fate during cortical neurogenesis. The...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, provides $629,510 to the Children's Research Institute to study the functional maturation of amygdala circuitry during adolescence. The goal is to understand the role of late-maturing neurons in the amygdala's circuitry, neuronal responsivity, and behavioral changes that occur during the transition from adolescence to adulthood. This includes examining...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,049,254 to Cold Spring Harbor Laboratory to investigate the role of transient neural connectivity in healthy and impaired cortical maturation. The 5-year research project (7/1/2024 - 1/31/2029) aims to elucidate the mechanisms by which sensory inputs and neuromodulation regulate the development of inhibitory neuron connectivity, and...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) is focused on investigating the neural circuits and cell types that modulate social approach and avoidance behaviors. The $885,500 award, with a project period from July 2024 to June 2026, will be used by the University of California, Davis to leverage the Fast Light and Calcium-Regulated Expression (FLICRE) system to tag and genetically define the specific...
The National Institute of Mental Health (NIMH) awarded a Project Grant (CFDA 93.242) in the amount of $200,000.00 to Virginia Polytechnic Institute & State University (Virginia Tech) to study sex differences in the integration of visual social stimuli and emotional auditory stimuli. The research aims to investigate the underlying neural circuit mechanisms that drive the synchronization of emotional responses in mice, and how these processes may differ between males and females. The project...
This federal Project Grant award for $185,625 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research on the neural mechanisms underlying socially transmitted aggression in mice. The primary objective is to study the role of familiarity in how witnessing aggressive behavior in familiar conspecifics can lead to the development of aggressive tendencies in observers. The research will use a novel social transmission...
The National Institute of Mental Health (NIMH) has awarded a $727,248 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The Trustees of the University of Pennsylvania, effective September 25, 2024, with a completion date of May 31, 2029. This grant will fund research to examine how mutations in the neurexin1 (NRXN1) gene, a genetic risk factor for multiple neuropsychiatric disorders, impact the function of striatal cholinergic interneurons and midbrain dopamine neurons. The...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $169,500.00 to Weill Medical College of Cornell University to identify the direct binding targets and transcriptional changes of the FOXP1 gene in human cortical neural progenitor cells and neurons. The research aims to further the understanding of the disease mechanisms underlying FOXP1 syndrome, a rare neurodevelopmental disorder causing...
This $1,505,818 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research at Rosalind Franklin University of Medicine & Science to investigate the role of the neurexin protein in social behavior and amygdala plasticity. The primary objective is to determine how disruption of the neurexin 1 gene, a high-confidence autism spectrum disorder (ASD) gene, impacts synaptic plasticity in the...
This Project Grant award of $196,460 from the National Institute of Mental Health (NIMH) under CFDA 93.242 - Mental Health Research Grants supports a research project at Emory University to elucidate the neural mechanisms underlying novelty-related social investigation in mice. The key objectives are to: Use cellular-resolution calcium imaging to determine how social recognition information and motivated social behaviors are encoded in specific neural pathways connecting the ventral hippocampus,...

The National Institute of Mental Health (NIMH) has awarded a Project Grant (CFDA 93.242 - Mental Health Research Grants) totaling $497,652.00 to the Children's Research Institute in Washington, D.C. The grant, titled "FOXP2 Genetic Control of Sex Differences in Amygdala-Driven Social Behavior", will support research examining the role of the FOXP2 transcription factor in the maturation of social brain circuitry in the amygdala during adolescence in male and female mice. The project aims to use CRISPR-Cas gene editing to delete FOXP2 in the medial amygdala and investigate the impact on social behavior and neuronal circuit function. In addition, the researchers will utilize genomic profiling to uncover the gene regulatory deficits underlying any observed behavioral and circuit-level changes. The overarching goal is to generate a mechanistic understanding of the genetic control of social brain formation and social behavior during adolescence, which is a critical period for the development of various neurodevelopmental and neurobehavioral disorders.

Generated 6/10/25, 2:58 AM